How big is the computational pathology market?

The global computational pathology market size was estimated at USD 728.68 million in 2025 and is expected to reach USD 781.51 million in 2026.

What is the computational pathology market growth?

The global computational pathology market is expected to grow at a compound annual growth rate of 9.21% from 2026 to 2033 to reach USD 1,447.62 million by 2033.

Which segment accounted for the largest computational pathology market share?

North America dominated the computational pathology market, with a share of 45.40% in 202. This is attributable to the rising adoption of digital pathology and AI-driven diagnostic tools. In addition, the increasing prevalence of chronic diseases, such as cancer, and the need for efficient and accurate diagnostic solutions are major growth drivers. Advancements in imaging technology and the expanding use of telepathology are propelling market expansion, enabling remote diagnostics and consultations.

Who are the key players in computational pathology market?

Some key players operating in the computational pathology market includes Leica Biosystems Nussloch GmbH (subsidiary of Danaher); Hamamatsu Photonics K.K.; Koninklijke Philips N.V.; Olympus Corporation; F. Hoffmann-La Roche Ltd.; Aiforia Technologies PLC; Epredia (3DHISTECH Ltd.); Visiopharm A/S; Proscia Inc.; Mindpeak GmbH; Akoya Biosciences, Inc. (a Quanterix company); Paige AI, Inc.; CellaVision; aetherAI; Qritive; IBEX Medical Analytics; Nucleai, Inc.

What are the factors driving the computational pathology market?

Key factors driving the market growth include advancements in artificial intelligence (AI) and machine learning (ML) technologies, increasing adoption of digital pathology, the rising prevalence of chronic diseases, and the demand for personalized medicine. In addition, regulatory support and increased R&D investments further fueling market growth.